ANA-ASH 1MG (ANASTRAZOLE 1MG) | Hormone Therapy Tablet
ANA-ASH 1MG (ANASTRAZOLE 1MG), an aromatase inhibitor used in hormone-sensitive breast cancer management. Supports estrogen reduction and long-term treatment outcomes.
ANA-ASH 1MG for Hormonal Therapy
Product Summary
ANA-ASH 1MG (ANASTRAZOLE 1MG) is a prescription aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It helps reduce estrogen production in the body, which may slow or stop the growth of certain breast cancer cells. Its targeted mechanism and once-daily dosing make it an important component of long-term hormonal therapy.
Product Full Description
ANA-ASH 1MG (ANASTRAZOLE 1MG) contains Anastrozole 1mg, a potent non-steroidal aromatase inhibitor. It is commonly prescribed for postmenopausal women with hormone-sensitive breast cancer. The medicine works by lowering estrogen levels through inhibition of the aromatase enzyme responsible for estrogen synthesis. Reduced estrogen availability limits the stimulation of estrogen-dependent cancer cells. It is widely used in both early-stage and advanced breast cancer management under medical supervision. Regular use as prescribed helps support long-term treatment goals.
Usage Instructions
Take ANA-ASH 1MG exactly as prescribed by your healthcare provider.
Swallow the tablet whole with a glass of water.
It may be taken with or without food.
Take the medicine at the same time each day for consistent results.
Do not alter the dosage or discontinue treatment without consulting your doctor.
Attend scheduled follow-up appointments and monitoring tests as advised.
Medicinal Advantages
Helps reduce estrogen production in postmenopausal women.
Supports treatment of hormone receptor-positive breast cancer.
May help decrease the risk of cancer recurrence following primary treatment.
Provides targeted hormonal therapy without directly affecting cancer cells through chemotherapy mechanisms.
Recommended in numerous oncology treatment guidelines for eligible patients.
Clinical studies have demonstrated the effectiveness of anastrozole in improving disease-free survival in appropriate patients.
Mechanism of Action
ANA-ASH 1MG (ANASTRAZOLE 1MG) works by selectively inhibiting the aromatase enzyme. Aromatase converts androgens into estrogens in peripheral tissues after menopause. By blocking this enzyme, the medicine significantly lowers circulating estrogen levels. Since many breast cancer cells rely on estrogen for growth and proliferation, reducing estrogen availability helps slow or prevent tumor progression and recurrence.
Off-Label Uses
Under specialist supervision, Anastrozole may sometimes be considered for:
Certain cases of male hormonal disorders associated with elevated estrogen levels.
Management of gynecomastia in selected patients.
Fertility-related hormonal protocols in specific clinical settings.
Other endocrine-related conditions where estrogen suppression may be beneficial.
Off-label use should only occur when recommended by a qualified healthcare professional.
Expert Advice
Take the medication consistently at the same time every day.
Follow your oncologist's treatment plan carefully.
Maintain regular health assessments and recommended laboratory monitoring.
Inform your healthcare provider about all medicines and supplements being used.
Ensure adequate nutritional support, including measures recommended by your doctor for bone health.
Never skip routine follow-up consultations during treatment.
Precautions
1. Pregnancy and Breastfeeding
ANA-ASH 1MG is generally intended for postmenopausal women. It should not be used during pregnancy or breastfeeding unless specifically directed by a healthcare professional due to potential risks.
2. Bone Health Monitoring
Long-term estrogen reduction may affect bone mineral density. Periodic bone health evaluations may be recommended to ensure appropriate management.
3. Liver Function Considerations
Patients with liver impairment should use this medicine cautiously, as metabolism and clearance may be affected. Medical supervision is advised.
4. Existing Cardiovascular Conditions
Patients with a history of heart or circulatory disorders should discuss their medical history with their healthcare provider before starting treatment.
5. Drug Interactions
Inform your physician about all prescription medicines, over-the-counter products, and supplements to avoid potential interactions.
Storage Conditions
Store below 25°C in a cool, dry place.
Keep the tablets in their original packaging.
Protect from excessive heat, moisture, and direct sunlight.
Keep out of reach of children and pets.
Do not use after the expiry date mentioned on the pack.
Frequently Asked Questions (FAQs)
1. What is ANA-ASH 1MG used for?
ANA-ASH 1MG is primarily used for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
2. How does ANA-ASH 1MG work?
It lowers estrogen levels by blocking the aromatase enzyme, which helps reduce stimulation of estrogen-dependent cancer cells.
3. Can ANA-ASH 1MG be taken with food?
Yes, it can be taken with or without food.
4. How often should ANA-ASH 1MG be taken?
It is typically taken once daily or as directed by a healthcare professional.
5. Is ANA-ASH 1MG a chemotherapy drug?
No. It is a hormonal therapy medicine classified as an aromatase inhibitor.
6. Can I stop taking ANA-ASH 1MG if I feel well?
No. Continue treatment exactly as prescribed and consult your doctor before making any changes.
7. Who should use ANA-ASH 1MG?
It is generally prescribed for postmenopausal women with hormone-sensitive breast cancer based on a physician's evaluation.
8. Does ANA-ASH 1MG require regular monitoring?
Yes. Regular follow-up visits and medical assessments are recommended throughout treatment.
Product Tags
ANA-ASH 1MG, ANASTRAZOLE 1MG, Aromatase Inhibitor
, Breast Cancer
Treatment, Hormona
l Therapy, Oncology Medicine
, Estrogen Suppressant
, Postmenopausal Therapy
, Cancer Care,
Prescription Medicine
, Anti-Estrogen Tablet
, Hormone Receptor Positive Breast Cancer
